WCG acquires PharmaSeek, to offer ‘unprecedented’ site support and guidance

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/AndreyPopov)
(Image: Getty/AndreyPopov)

Related tags WCG PharmaSeek Clinical trial sites

Through the combined offerings of WCG and PharmaSeek, the companies will be able to make a clinical trial site’s success both ‘predictable and achievable,’ says CEO.

WIRB-Copernicus Group’s (WCG) Clinical Services Division as acquired PharmaSeek and its wholly-owned subsidiaries PFS Clinical and PatientWise, which provide administrative, consulting, patient recruitment, and training solutions for clinical research sites.

Nicolas Cindric, PharmaSeek CEO, told us the company has been approached for acquisition in the past, but never found the right fit. “With WCG, the stars just seemed to align,”​ he said.

PharmaSeek will continue to operate independently from its headquarters in Madison, WI, with access to capital, expertise, and corporate operational support from WCG. PharmaSeek clients also will be invited to join WCG’s Global Research Network (GRN).

“The clinical research landscape is changing,”​ said Donald Deieso, PhD, executive chairman and CEO, WCG, “protocols are more complex and research sponsors are using fewer sites.”

“In order to increase profitability, sites must maximize the efficiency with which they conduct existing research while positioning themselves to attract additional sponsor funding. A challenging proposition to even the most experienced sites, this ‘two-step’ is particularly difficult for newcomers, and is often perceived as a barrier to entry,”​ Deieso told us.

To encourage first-time investigators and new sites to participate in clinical research, Deieso said it is ‘imperative’ that the industry provide accessible solutions that enable sites to benchmark performance, manage study-related activities, increase patient enrollment, and simplify payments.

Said Deieso, “Through the power of our combined solutions, WCG and PharmaSeek offer unprecedented support and guidance, making a site’s success both predictable and achievable.”

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us